The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus

NCT06362005 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-12-31

No results posted yet for this study

Summary

evaluate clinically and biochemically the efficacy of topically applied selenium as complementary or alternative to triamcinolone acetonide 0.1% and tacrolimus 0.1% in patients with oral lichen planus.

Conditions

  • Lichen Planus, Oral

Interventions

DRUG

Triamcinolone Acetonide 0.1% Oint

RCT

DRUG

Tacrollimus Topical

RCT

DRUG

Selenium

RCT

DRUG

Selenium & Triamcinolone Acetonide 0.1% Oint

RCT

DRUG

Selenium& Tacrollimus topical

RCT

Sponsors & Collaborators

  • Sphinx university

    collaborator OTHER
  • Al-Azhar University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-07-01
Completion
2025-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06362005 on ClinicalTrials.gov